Employees of the Novosibirsk State Scientific Center for Viral Biotechnologies (SSC VB) “Vector” of Rospotrebnadzor have successfully completed work on a unique vaccine for the prevention of Ebola. The drug called “EpiVacEbola” was registered in March 2018 and approved for use in medical and prophylactic institutions.
The development brings Russian virologists and microbiologists to the forefront in the fight against one of the most dangerous diseases in the world. Four years ago, the Ebola epidemic in West Africa killed more than 11,000 people and caused panic around the world. Since then, pharmaceutical companies and scientific centers in many countries have been trying to find a weapon against this terrible disease.
The Novosibirsk vaccine “EpiVacEbola” was created in a short time using proprietary technology. Scientists say that its structure vaguely resembles the tick-borne encephalitis vaccine, but it is more perfect. The study of the characteristics and properties of the vaccine, as well as obtaining permits for testing the drug were carried out in strict accordance with modern international standards and protocols.
Numerous preclinical and clinical studies of the new vaccine, in which 360 volunteers participated, showed that the EliVacEbola vaccine is more effective in comparison with foreign analogues.
According to Novosibirsk scientists, previously presented drugs for the prevention of Ebola have side effects, ranging from pain in muscles and joints, changes in blood clotting time, ending with jaundice and fever.
In turn, according to the testimony of the developers, the side effects of the EliVakEbola vaccine of the Federal Service for Consumer Rights Protection and Human Welfare were recorded only in 5% of cases and were expressed in a slight increase in body temperature. The achievement of Novosibirsk scientists has become a significant contribution of Russia to the fight against the Ebola virus and gives all of humanity hope that the threat of an epidemic will forever be a thing of the past.
The 2014-16 Ebola outbreak in West Africa was the largest and deadliest since the virus was discovered. During the epidemic, about 28.5 thousand cases of infection and more than 11 thousand deaths were recorded. The World Health Organization (WHO) was forced to declare the epidemic “a threat of international importance.”
Specialists from Rospotrebnadzor and the Russian company RUSAL played an important role in the fight against the epidemic. Our compatriots were among the first to start helping the residents of the Republic of Guinea, who found themselves in the very epicenter of the crisis. A mobile brigade of Rospotrebnadzor was sent to the country, which had been functioning for a year and a half in the very outbreak of Ebola. In 2015 RUSAL built a modern Scientific Clinical and Diagnostic Center for Epidemiology and Microbiology (NKDTSEM) in 50 days. In collaboration with Rospotrebnadzor and its scientific departments, the center has created the most modern laboratory complex in West Africa to combat especially dangerous infections. This laboratory has brought the national sanitary security system in Guinea to a qualitatively new level, making it possible to promptly diagnose especially dangerous infections. Also, specialists of Rospotrebnadzor on the basis of the center trained more than 400 Guinean medical workers in 10 educational programs (ensuring biological safety, methods of epidemiological surveillance, laboratory diagnostics, etc.). During the epidemic, Russian doctors provided free and qualified assistance to more than 4.5 thousand residents of the Kindia province.
Cooperation between Rospotrebnadzor and RUSAL has become a successful example of the implementation of the principles of public-private partnership in solving global social problems. The total investment of RUSAL and the Russian Federation in the fight against the spread of the Ebola virus amounted to about $ 20 million, and thanks to the joint efforts of the state and business, it was possible to stop the spread of the epidemic.